Completed PHASE3 INTERVENTIONAL NCT00136110

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS

Sponsor: Princess Beatrix Muscle Foundation

Conditions Amyotrophic Lateral Sclerosis

Updated 5 times since 2017 Last updated: Apr 30, 2007 Started: Apr 30, 2005 Completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Amyotrophic Lateral Sclerosis and is currently completed. Princess Beatrix Muscle Foundation leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Princess Beatrix Muscle Foundation
UMC Utrecht

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands